Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

1mon ago, source: Business Insider

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”) today announced financial results for the fourth quarter and fiscal ...

Indaptus Therapeutics Stock (NASDAQ:INDP), Analyst Ratings, Price Targets, Predictions

10d ago, source: Benzinga.com

Indaptus Therapeutics Inc has a consensus price target of $14, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC ...

Indaptus Therapeutics Stock (NASDAQ:INDP), Quotes and News Summary

26d ago, source: Benzinga.com

Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter ...

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting

14d ago, source: Business Insider

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments ...

Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference

28d ago, source: Yahoo Finance

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection ...

Indaptus Therapeutics Inc INDP

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Indaptus Therapeutics Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Indaptus Therapeutics Inc INDP

13d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Indaptus Therapeutics Inc (INDP)

14d ago, source: Investing

Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Oil & Gas, Basic Materials and Industrials sectors led shares higher. At the close in NYSE,... Investing.com ...